Results 201 to 210 of about 30,760,761 (278)

Long non-coding RNA PCAT18 defines a leukemia-specific regulatory network in pediatric T-ALL. [PDF]

Sci Rep
Altieri F, Pecoraro G, Costabile V, de Vera d'Aragona RP, Becchimanzi G, Beneduce G, Parasole R, Smaldone G.   +7 more
europepmc   +1 more source

Takeover Vulnerability and the Discipline of ESG Overinvestment

Business Strategy and the Environment, Volume 35, Issue 6, Page 9048-9081, September 2026.
ABSTRACT While takeovers serve a disciplinary role by replacing inefficient managers, the threat of takeovers may compel firms to divert attention from Environmental, Social and Governance (ESG) efforts as a strategic response to external pressure, especially when such firms are already overinvesting in ESG.
Abongeh Tunyi, Ruth O. Sagay, Reon Matemane   +2 more
wiley   +1 more source

Safety and efficacy of chidamide for maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with T-ALL/T-LBL. [PDF]

Ann Hematol
Wang K, Li X, Li X, Yuan X, Chen X, Lai X, Li N, Chen P.   +7 more
europepmc   +1 more source

Association of Ferritin Levels With Cytokine Release Syndrome in CAR T‐Cell Therapy: A Systematic Review and Meta‐Analysis

Cancer Medicine, Volume 15, Issue 9, September 2026.
CAR T‐cell infusion can induce production of excessive cytokines resulting in cytokine release syndrome (CRS). Ferritin is elevated in severe CRS and both pre‐ and post‐infusion levels are associated with poor survival. ABSTRACT Background Ferritin elevation is frequently observed during cytokine release syndrome (CRS) following CAR T‐cell therapy ...
Ranjit Sah, Abhinav Bhattarai, Sangam Shah, Rachana Mehta, Sanjit Sah, Zeeshan Solangi, George P. Sorescu   +6 more
wiley   +1 more source

Leukapheresis in Pediatric T-ALL with Extreme Hyperleukocytosis: A Case Highlighting the Importance of Early Recognition. [PDF]

J Investig Med High Impact Case Rep
Guild A, Salomon J, Thakker J, Williams SM, Ford J.   +4 more
europepmc   +1 more source

Diagnostic BMI and Induction Therapy Weight Change Associated With Hepatotoxicity in Pediatric Patients With Acute Lymphoblastic Leukemia

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Hepatotoxicity is a common treatment‐related complication in pediatric acute lymphoblastic leukemia (ALL). Excess adiposity at diagnosis has been identified as a risk factor, but the impact of weight change during therapy has not been examined.
Emily J. Mason, John P. Woodhouse, Jeremy M. Schraw, Joanna S. Yi, Karen R. Rabin, M. Monica Gramatges, Mark C. Zobeck, Baojiang Chen, Melissa B. Harrell, Olga A. Taylor, Michael E. Scheurer, Philip J. Lupo, Van Huynh, Steven D. Mittelman, Etan Orgel, Austin Brown   +15 more
wiley   +1 more source

Toward Equitable Risk Classification for All Patients with T-ALL. [PDF]

Blood Cancer Discov
de Smith AJ.
europepmc   +1 more source

A Novel Immunotherapy for T-ALL

The Hematologist, 2019
David T. Teachey, Caroline Diorio
openaire   +1 more source

Mitochondrial Genomic Alterations in Pediatric Acute Lymphoblastic Leukemia: Implications for Methotrexate‐Induced Neurotoxicity and Ethnic Disparities

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Methotrexate (MTX)‐induced neurotoxicity is a serious complication in pediatric acute lymphoblastic leukemia (ALL), with observed ethnic disparities in risk. To investigate the role of mitochondrial DNA (mtDNA) variation, we performed whole mtDNA sequencing in 94 children with ALL, including 62 Hispanic patients.
Jing Han, Shahram Arsang‐Jang, Paul L. Auer, Wael Saber, Laura Michaelis, Raul Urrutia, Xiaowu Gai, Philip Lupo, Michael Scheurer, Jing Dong   +9 more
wiley   +1 more source

Chronic hepatitis b coinfection and survival in pediatric T-ALL: A propensity-matched analysis. [PDF]

iScience
Zhang Y, Wu R, Zhang Y, Zhao Y, Zhong X, Jin X, Zhang C, Chang J.   +7 more
europepmc   +1 more source